• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.29% Nasdaq Down0.03%

    More On BNC.TO



    News & Info


    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates


    • Major Holders
    • Insider Transactions
    • Insider Roster


    Telesta Therapeutics Inc. (BNC.TO)

    0.21 Down 0.01(2.33%) Nov 28
    Add to Portfolio
    ProfileGet Profile for:
    Telesta Therapeutics Inc.
    231 Dundas Street East
    Belleville, ON K8N 1E2
    Canada - Map
    Phone: 613-966-8058
    Fax: 613-966-4177
    Website: http://www.telestatherapeutics.com

    Index Membership:N/A
    Full Time Employees:N/A

    Business Summary 

    Telesta Therapeutics Inc., a late clinical stage biopharmaceutical company, engages in the development, manufacture, marketing, and licensing/acquisition of proprietary and therapeutic products for the human health markets worldwide. Its lead product, Mycobacterial Cell Wall-Nucleic Acid Complex (MCNA) suspension, is a complex biologic immunotherapy/immunomodulator designed for the treatment of non-muscle-invasive bladder cancer in humans, which has completed Phase III clinical trials. The company was formerly known as Bioniche Life Sciences Inc. and changed its name to Telesta Therapeutics Inc. in November 2014. Telesta Therapeutics Inc. was founded in 1979 and is headquartered in Belleville, Canada.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Telesta Therapeutics Inc.

    Key Executives 
    Dr. Michael J. Berendt Ph.D., 66
    Chief Exec. Officer, Chief Scientist Officer and Director
    Mr. Graeme McRae , 67
    Founder, Chairman Emeritus and Board Observer
    Mr. Brian D. Ford CA,
    Chief Financial Officer
    Mr. Donald Olds M.Sc., MBA, 55
    Chief Operating Officer and Corp. Sec.
    Mr. Mohamed Elrafih ,
    VP of Manufacturing Operations
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in CAD.